Simplex Trading’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,350
Closed -$862K 8428
2024
Q4
$848K Sell
9,350
-1,195
-11% -$110K ﹤0.01% 3010
2024
Q3
$1.02M Buy
10,545
+2,112
+25% +$206K ﹤0.01% 2904
2024
Q2
$774K Buy
+8,433
New +$782K ﹤0.01% 3183
2024
Q1
Sell
-4,378
Closed -$410K 8762
2023
Q4
$416K Buy
4,378
+2,119
+94% +$198K ﹤0.01% 3890
2023
Q3
$210K Sell
2,259
-779
-26% -$72K ﹤0.01% 4295
2023
Q2
$277K Buy
+3,038
New +$249K ﹤0.01% 3939
2023
Q1
Sell
-1,296
Closed -$112K 8920
2022
Q4
$108K Buy
+1,296
New +$117K ﹤0.01% 4970
2022
Q2
Sell
-17,507
Closed -$2.24M 9861
2022
Q1
$3.02M Buy
+17,507
New +$2.62M ﹤0.01% 1693
2021
Q4
Sell
-529
Closed -$85K 10390
2021
Q3
$138K Sell
529
-100
-16% -$20.8K ﹤0.01% 6152
2021
Q2
$154K Buy
629
+551
+706% +$145K ﹤0.01% 6092
2021
Q1
$20K Sell
78
-4,274
-98% -$1.21M ﹤0.01% 7439
2020
Q4
$1.28M Buy
+4,352
New +$1.12M ﹤0.01% 2247
2020
Q1
Sell
-8,192
Closed -$1.46M 7523
2019
Q4
$1.37M Buy
+8,192
New +$1.22M ﹤0.01% 1806
2019
Q2
Sell
-5,423
Closed -$644K 7024
2019
Q1
$668K Buy
+5,423
New +$681K ﹤0.01% 2355
2017
Q4
Sell
-309
Closed -$16.3K 5912
2017
Q3
$17K Buy
+309
New +$16.3K ﹤0.01% 3277
2017
Q2
Sell
-80
Closed -$4.66K 6010
2017
Q1
$4K Buy
+80
New +$3.82K ﹤0.01% 4722
2016
Q3
Sell
-5,066
Closed -$253K 5725
2016
Q2
$255K Buy
+5,066
New +$256K 0.02% 861
2016
Q1
Sell
-2,170
Closed -$83.7K 5509
2015
Q4
$85K Sell
2,170
-567
-21% -$22.7K 0.01% 1484
2015
Q3
$103K Sell
2,737
-1,479
-35% -$62.4K 0.01% 1390
2015
Q2
$167K Buy
4,216
+3,185
+309% +$99.2K 0.01% 894
2015
Q1
$27K Sell
1,031
-2,614
-72% -$73.8K ﹤0.01% 2066
2014
Q4
$107K Buy
+3,645
New +$90K 0.01% 898

Other funds holding AMED

Simplex Trading's AMED Position: Q1 2025 in Review

Simplex Trading sold out of Amedisys (AMED) in Q1 2025, closing a stake of 9,350 shares — an estimated $862K sold.

Simplex Trading first reported a position in AMED in Q4 2014 and held it in 22 quarters. The position peaked at $3.02M in Q1 2022. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Simplex Trading reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 9,350 Amedisys shares in Q1 2025, an estimated $862K.
  • Simplex Trading first reported a position in Amedisys in Q4 2014 and held it in 22 quarters.
  • Simplex Trading's Amedisys position peaked at $3.02M in Q1 2022.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.